cholesterol

  • Actavis: Launch of Cholesterol Drug in Spain

    Actavis Group has announced that its third-party sales division, Medis, has delivered 30 million tablets of Atorvastatin to its clients in Spain. This is the first generic version of the blockbuster molecule to reach the Spanish market, according to…

    cholesterol | 01 November 2009

  • China Pharma Holdings: SFDA Approval for Clinical Trials

    China Pharma Holdings has received official approval from China's State Food and Drug Administration (SFDA) to enter Phase I and Phase II clinical trials to test the efficacy of its cholesterol-lowering drug, Rosuvastatin. The company plans to be…

    cholesterol | 29 June 2009

  • Cholesterol Drug Cuts Heart Risk

    Data from a study presented at the American Heart Association Scientific Sessions demonstrated that Crestor (rosuvastatin calcium) reduced major cardiovascular (CV) events by 44% compared to placebo. It also reduced the combined risk of cardiovascula…

    cholesterol | 30 December 2008